Nonetheless, if it is accepted that plasma P-tau 181 or 217 are part of the biological process defining AD then elevated plasma P-tau 181 or 217 levels even in asymptomatic individuals must be considered a component of AD pathogenesis as well as changes in body weight. Here, MAPT is linked to Alzheimer disease.